EVIDENCE FOR POLYMORPHIC OXIDATION OF SPARTEINE IN JAPANESE SUBJECTS

被引:58
作者
ISHIZAKI, T
EICHELBAUM, M
HORAI, Y
HASHIMOTO, K
CHIBA, K
DENGLER, HJ
机构
[1] YAMANASHI MED COLL,DEPT PHARMACOL,KOFU,JAPAN
[2] UNIV BONN,DEPT MED,D-5300 BONN,FED REP GER
关键词
D O I
10.1111/j.1365-2125.1987.tb03080.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:482 / 485
页数:4
相关论文
共 16 条
  • [1] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE
    BERTILSSON, L
    DENGLER, HJ
    EICHELBAUM, M
    SCHULZ, HU
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 153 - 155
  • [2] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS
    CLARK, DWJ
    [J]. DRUGS, 1985, 29 (04) : 342 - 375
  • [3] INTER-ETHNIC DIFFERENCE IN SPARTEINE OXIDATION AMONG GHANAIANS AND GERMANS
    EICHELBAUM, M
    WOOLHOUSE, NM
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (01) : 79 - 83
  • [4] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
    EICHELBAUM, M
    SPANNBRUCKER, N
    STEINCKE, B
    DENGLER, HJ
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
  • [5] THE GENETIC-POLYMORPHISM OF SPARTEINE METABOLISM
    EICHELBAUM, M
    REETZ, KP
    SCHMIDT, EK
    ZEKORN, C
    [J]. XENOBIOTICA, 1986, 16 (05) : 465 - 481
  • [6] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES
    EICHELBAUM, M
    BERTILSSON, L
    SAWE, J
    ZEKORN, C
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) : 184 - 186
  • [7] EICHELBAUM M, 1984, FED PROC, V43, P2298
  • [8] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
  • [9] IDLE JR, 1984, 2ND P WORLD C CLIN P, P148
  • [10] DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINE
    INABA, T
    OTTON, SV
    KALOW, W
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) : 547 - 549